“ Recently we have patented the new MMCR technology (for multi-layer microparticle controlled-release system) enabling us to convert a well-established API from tablets to syrup, with the… ”
In Conversation
“ I predict that some of the changes in consumer preferences will remain after the pandemic ends. Therefore, we as an organisation need to be ready for… ”
“ We have several agreements in place ... We hope that this combined effort will lead to a number of successful COVID-vaccines that will use our adjuvant… ”
“ We want to combine the agility of a biotech with the experience of a Big Pharma company ”
“ In order to increase the robustness of the global supply chain, CDMOs need to step up and play a larger role than ever before and need… ”
“ The Chiesi Culture [has] a sense of closeness, both within our affiliate and to our headquarters. Overall: “We are large enough to cope and small enough… ”
“ If the restrictions to parallel trade were always justified, limited in time and scope, and properly implemented, no countries would experience the negative effects of exports,… ”
“ Nowadays, there are a substantial number of drugs unavailable in Belgium, but readily available in other European countries. Through parallel imports, we are able to safely… ”
“ When no bridging process can be found, Pfizer donates the medicines to hospitals that request it. Half of Pfizer’s investments are done through donations, as a… ”
“ High scientific quality is also really important to us, as well as transparency in our reporting. This way, we aim to contribute to sustainable, accessible and… ”
“ From early research and development, through manufacturing and drug delivery to the patient, our employees in Belgium make a significant contribution to the health of patients… ”
“ We need to have everyone on board, in order to improve the quality of cancer care in Belgium, attract more clinical trials and be able to… ”
